CTICases ← All cases

Naltrexone (Vivitrol)-Induced Acute Eosinophilic Pneumonia

Imaging findings

A patient presenting to the emergency department with shortness of breath had a chest radiograph with subtly abnormal lungs and a CT showing extensive diffuse multilobar confluent ground-glass opacity with a lesser degree of consolidation, without pulmonary embolism. Laboratory workup showed peripheral eosinophilia (9.5%) and marked eosinophilia on bronchoalveolar lavage (70%), and the patient had recently been started on naltrexone (Vivitrol); the opacities resolved on follow-up imaging after the drug was stopped and steroids were given.

Key takeaways

Naltrexone/Vivitrol, an opioid antagonist used to reduce cravings in substance use disorder, is a recognized rare cause of acute eosinophilic pneumonia, and a compatible clinical picture of diffuse ground-glass opacity with peripheral and bronchoalveolar lavage eosinophilia in a patient on this drug should prompt drug cessation and steroid treatment, with an expectation of resolution on imaging.

AI-assisted summary — may contain errors. Verify against the source video. Learn more

More from this webinar

See all cases from June 28, 2018 →

Related ILD cases

Browse all ILD cases →